Literature DB >> 15895252

Reduction of drug leakage by negative-balance isolated pelvic perfusion: correlation between leakage and in-out flow rate in a pig model.

Satoru Murata1, Hiroyuki Tajima, Gen-ichi Kusakai, Tatsuo Kumazaki, Yutaka Abe, Shiro Onozawa, Yasushige Komada, Yukihiro Kondo, Ryoji Kimata, Seiichiro Himeno, Mitsuo Satake.   

Abstract

PURPOSE: Isolated pelvic perfusion (IPP) therapy exposes target tissues to high doses of anticancer drugs with low systemic concentrations, but the major drawback is drug leakage into the systemic circulation, which often thwarts the increased drug concentration. In this study, the efficacy of altering the in-out flow rate during IPP in order to decrease the leakage was assessed in adult pigs.
METHODS: The abdominal aorta and the infrarenal vena cava were occluded with two balloon catheters, blood in the extracorporeal circuit was circulated with twin rotary pumps, and the IPP was performed with platinum. Three sets of in-out flow rates were used, and the degree of drug leakage into the systemic circulation was evaluated. The volume of blood withdrawn was equal to the volume returned (300 ml/min; group A), 5% higher (group B), or 10% higher (group C). The platinum concentrations in the pelvic circulation, systemic circulation, and urine were measured and compared.
RESULTS: The average and maximum plasma platinum concentrations in the pelvic circulation did not significantly differ among the three groups. The plasma platinum concentrations in the systemic venous circulation of the three groups significantly (P<0.01) decreased as the volume withdrawn during IPP increased. The percentage of platinum eliminated in the urine during IPP was significantly (P<0.01) lower in group B and C than in group A.
CONCLUSIONS: Setting the volume withdrawn higher than the volume returned decreased leakage into the systemic circulation under isolated pelvic perfusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895252     DOI: 10.1007/s00432-004-0666-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  The use of intravascular balloon catheters for isolation of the pelvic vascular bed during pump-oxygenator perfusion of cancer chemotherapeutic agents.

Authors:  E WATKINS; A C HERING; R LUNA; H D ADAMS
Journal:  Surg Gynecol Obstet       Date:  1960-10

2.  Regional perfusion of the pelvis: consideration of the "leakage" problem.

Authors:  W LAWRENCE; P KUEHN; S MORI; J W POPPELL; B CLARKSON
Journal:  Surgery       Date:  1961-07       Impact factor: 3.982

3.  Treatment of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents.

Authors:  W G AUSTEN; A P MONACO; G S RICHARDSON; W H BAKER; R S SHAW; J W RAKER
Journal:  N Engl J Med       Date:  1959-11-19       Impact factor: 91.245

4.  Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit.

Authors:  O CREECH; E T KREMENTZ; R F RYAN; J N WINBLAD
Journal:  Ann Surg       Date:  1958-10       Impact factor: 12.969

5.  Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique.

Authors:  H J Wanebo; M A Chung; A I Levy; P S Turk; M P Vezeridis; J F Belliveau
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

6.  Pharmacologic rationale for regional drug delivery.

Authors:  J M Collins
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

7.  Treatment of locally recurrent rectal carcinoma--results and prognostic factors.

Authors:  C S Wong; B J Cummings; J D Brierley; C N Catton; M McLean; P Catton; Y Hao
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-15       Impact factor: 7.038

8.  A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion.

Authors:  H J Wanebo; J F Belliveau
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

9.  Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.

Authors:  P S Turk; J F Belliveau; J W Darnowski; M C Weinberg; L Leenen; H J Wanebo
Journal:  Arch Surg       Date:  1993-05

10.  Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer.

Authors:  S Guadagni; K R Aigner; G Palumbo; M Cantore; G Fiorentini; T Pozone; M Deraco; M Clerico; P K Chaudhuri
Journal:  J Clin Pharmacol       Date:  1998-10       Impact factor: 3.126

View more
  5 in total

1.  The negative-balance isolated pelvic perfusion method using ultrahigh-dose cisplatin for invasive bladder cancer with poor risk.

Authors:  Ryoji Kimata; Yukihiro Kondo; Kaoru Nemoto; Satoru Murata; Tatsuo Kumazaki
Journal:  Int J Clin Oncol       Date:  2010-04-21       Impact factor: 3.402

2.  Large volume loading to prevent cisplatin-induced nephrotoxicity during negative-balance isolated pelvic perfusion.

Authors:  Keiko Nakazato; Chol Kim; Katsuyuki Terajima; Satoru Murata; Hitoshi Fujitani; Kazuhiro Nakanishi; Hiroyuki Tajima; Tatsuo Kumazaki; Atsuhiro Sakamoto
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-15       Impact factor: 4.553

3.  Changes in pelvic and systemic platinum concentrations during negative-balance isolated pelvic perfusion: correlation between platinum concentration and method of administration in a pig model.

Authors:  Satoru Murata; Hiroyuki Tajima; Yutaka Abe; Shiro Onozawa; Fumio Uchiyama; Hiromitsu Hayashi; Ryoji Kimata; Kazuhiro Nomura
Journal:  J Cancer Res Clin Oncol       Date:  2007-01-24       Impact factor: 4.322

4.  Pilot study of transcatheter arterial ethanol embolization under closed renal circuit for large renal cell carcinomas.

Authors:  Satoru Murata; Hiroyuki Tajima; Shiro Onozawa; Shinichiro Kumita; Yukihiro Kondo; Kazuhiro Nomura
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 7.034

5.  Stop-Flow Pelvic Chemoperfusion for the Treatment of Malignant Pelvic Bone Tumors: A Preliminary Study.

Authors:  Han Wang; Xiaodong Tang; Lu Xie; Sen Dong; Chen Chen; Wei Guo
Journal:  Orthop Surg       Date:  2020-04-03       Impact factor: 2.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.